Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $166.60 | Total: $833.00 |
| 1 | 10 | $141.12 | Total: $1,411.20 |
| 1 | 25 | $119.56 | Total: $2,989.00 |
| 1 | 50 | $101.92 | Total: $5,096.00 |
| 1 | 100 | $88.20 | Total: $8,820.00 |
Overview
KY-02327, a metabolically stabilized analog of KY-02061, serves as a potent inhibitor of the Dishevelled (Dvl)-CXXC5 interaction. This compound activates the Wnt?-catenin pathway, thereby promoting osteoblast differentiation.
Chemical Properties
| Molecular Formula | C20H27N3O4 |
| Molecular Weight | 373.45 |
| CAS Numbers | 2093407-25-9 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | C(C(NCCN1CCCCC1)=O)N2C=3C(C=C2C(OCC)=O)=CC(O)=CC3 |
Storage and Handling
0C Short Term, -20C Long Term
References
Kim HY, et al. Small molecule inhibitors of the Dishevelled-CXXC5 interaction are new drug candidates for bone anabolic osteoporosis therapy. EMBO Mol Med. 2016;8[4] 375-387.